ENTITY
CureVac NV

CureVac NV (CVAC US)

10
Analysis
Health CareUnited States
CureVac N.V. operates as a global clinical-stage biopharmaceutical company. The Company focuses on developing a new class of transformative medicines based on messenger ribonucleic acid that has the potential to improve the lives of people. CureVac serves customers worldwide.
more
Refresh
Company Presentation24 Apr 2024 21:00
Company Presentation14 Nov 2023 22:00
Company Presentation25 Apr 2023 21:00
Company Presentation06 Jan 2023 22:00
Company Presentation16 Nov 2022 18:25
x